- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Conivaptan is a cardiovascular drug used to treat hyponatremia, a condition in which the body has an abnormally low level of sodium in the blood. It is a vasopressin receptor antagonist, meaning it works by blocking the action of the hormone vasopressin, which helps regulate the body's water balance. Conivaptan is administered intravenously and is available in both a short-acting and a long-acting form. It is used to treat both euvolemic and hypervolemic hyponatremia, and is often used in combination with other medications.
Conivaptan is a relatively new drug, having been approved by the US Food and Drug Administration in 2004. It is marketed by several pharmaceutical companies, including Astellas Pharma, Baxter International, and Hospira. It is also available in generic form. Conivaptan is used in hospitals and other healthcare settings, as well as in home care settings. Show Less Read more